Find Altiratinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1345847-93-9, Dcc-2701, Dp-5164, Altiratinib [usan], Altiratinib (usan), 1,1-cyclopropanedicarboxamide, n-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-
Molecular Formula
C26H21F3N4O4
Molecular Weight
510.5  g/mol
InChI Key
GNNDEPIMDAZHRQ-UHFFFAOYSA-N
FDA UNII
T678746713

Altiratinib
Altiratinib is an orally bioavailable inhibitor of c-Met/hepatocyte growth factor receptor (HGFR), vascular endothelial growth factor receptor type 2 (VEGFR2), Tie2 receptor tyrosine kinase (TIE2), and tropomyosin receptor kinase (Trk), with potential antiangiogenic and antineoplastic activities. Upon administration, altiratinib selectively binds to c-Met, VEGFR2, Tie2 and Trk tyrosine kinases, which may lead to the inhibition of endothelial cell migration, proliferation and survival. This also results in both an inhibition of tumor cell proliferation and increased tumor cell death in c-Met/VEGFR2/Tie2/Trk-expressing cells. These receptor tyrosine kinases (RTKs), frequently overexpressed or mutated by a variety of tumor cell types, play crucial roles in the regulation of angiogenesis, tumor cell growth and survival.
1 2D Structure

Altiratinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
2.1.2 InChI
InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)
2.1.3 InChI Key
GNNDEPIMDAZHRQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F
2.2 Other Identifiers
2.2.1 UNII
T678746713
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dcc-2701

2.3.2 Depositor-Supplied Synonyms

1. 1345847-93-9

2. Dcc-2701

3. Dp-5164

4. Altiratinib [usan]

5. Altiratinib (usan)

6. 1,1-cyclopropanedicarboxamide, N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-

7. 1,1-cyclopropanedicarboxamide, N-(4-((2-((cyclopropylcarbonyl)amino)-4-pyridinyl)oxy)-2,5-difluorophenyl)-n'-(4-fluorophenyl)-

8. N-(4-((2-((cyclopropylcarbonyl)amino)pyridin-4-yl)oxy)-2,5-difluorophenyi)-n-(4- Fluorophenyl)cyclopropane-1,1-dicarboxamide

9. T678746713

10. 1-n'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

11. N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-2,5-difluorophenyl)-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide.

12. N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

13. Unii-t678746713

14. Altiratinib;dcc2701

15. Altiratinib [inn]

16. Altiratinib(dcc-2701)

17. Altiratinib [who-dd]

18. Schembl139906

19. Gtpl9174

20. Chembl3545365

21. Dcc-270

22. Dcc2701

23. Ex-a902

24. Bcp15682

25. Hy-b0791

26. Bdbm50193395

27. Mfcd28900672

28. Nsc784590

29. S6412

30. Akos026750329

31. Zinc113198271

32. Cs-3944

33. Nsc-784590

34. Sb18876

35. Ncgc00480913-04

36. Ac-35383

37. N-(4-(2-(cyclopropanecarboxamido)pyridin-4-yloxy)-2,5-difluorophenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

38. Ft-0700171

39. A14387

40. D10862

41. F11464

42. A887875

43. J-690136

44. Q27074416

45. 1,1-cyclopropanedicarboxamide, N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n-(4-fluorophenyl)-

46. 4-{5-[(e)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4h-1,2,4-triazol-3-yl}vinyl]-1,3,4-oxadiazol-2-yl}benzonitrile

47. A9i

48. N-1'-[4-[2-(cyclopropylcarbonylamino)pyridin-4-yl]oxy-2,5-bis(fluoranyl)phenyl]-n-1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; 1-n'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-n-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

2.4 Create Date
2011-12-05
3 Chemical and Physical Properties
Molecular Weight 510.5 g/mol
Molecular Formula C26H21F3N4O4
XLogP34.3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass510.15148965 g/mol
Monoisotopic Mass510.15148965 g/mol
Topological Polar Surface Area109 Ų
Heavy Atom Count37
Formal Charge0
Complexity863
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1345847-93-9 / Altiratinib API manufacturers, exporters & distributors?

Altiratinib manufacturers, exporters & distributors 1

61

PharmaCompass offers a list of Altiratinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Altiratinib manufacturer or Altiratinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Altiratinib manufacturer or Altiratinib supplier.

PharmaCompass also assists you with knowing the Altiratinib API Price utilized in the formulation of products. Altiratinib API Price is not always fixed or binding as the Altiratinib Price is obtained through a variety of data sources. The Altiratinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Altiratinib

Synonyms

1345847-93-9, Dcc-2701, Dp-5164, Altiratinib [usan], Altiratinib (usan), 1,1-cyclopropanedicarboxamide, n-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-n'-(4-fluorophenyl)-

Cas Number

1345847-93-9

Unique Ingredient Identifier (UNII)

T678746713

About Altiratinib

Altiratinib is an orally bioavailable inhibitor of c-Met/hepatocyte growth factor receptor (HGFR), vascular endothelial growth factor receptor type 2 (VEGFR2), Tie2 receptor tyrosine kinase (TIE2), and tropomyosin receptor kinase (Trk), with potential antiangiogenic and antineoplastic activities. Upon administration, altiratinib selectively binds to c-Met, VEGFR2, Tie2 and Trk tyrosine kinases, which may lead to the inhibition of endothelial cell migration, proliferation and survival. This also results in both an inhibition of tumor cell proliferation and increased tumor cell death in c-Met/VEGFR2/Tie2/Trk-expressing cells. These receptor tyrosine kinases (RTKs), frequently overexpressed or mutated by a variety of tumor cell types, play crucial roles in the regulation of angiogenesis, tumor cell growth and survival.

Altiratinib Manufacturers

A Altiratinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Altiratinib, including repackagers and relabelers. The FDA regulates Altiratinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Altiratinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Altiratinib Suppliers

A Altiratinib supplier is an individual or a company that provides Altiratinib active pharmaceutical ingredient (API) or Altiratinib finished formulations upon request. The Altiratinib suppliers may include Altiratinib API manufacturers, exporters, distributors and traders.

Altiratinib GMP

Altiratinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Altiratinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Altiratinib GMP manufacturer or Altiratinib GMP API supplier for your needs.

Altiratinib CoA

A Altiratinib CoA (Certificate of Analysis) is a formal document that attests to Altiratinib's compliance with Altiratinib specifications and serves as a tool for batch-level quality control.

Altiratinib CoA mostly includes findings from lab analyses of a specific batch. For each Altiratinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Altiratinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Altiratinib EP), Altiratinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Altiratinib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty